Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Self-emulsified 2-methoxyestradiol intravenous injection and preparation method thereof

A technology of methoxyestradiol and injection, applied in the field of self-emulsifying 2-methoxyestradiol intravenous injection and its preparation, can solve the problem of self-emulsifying 2-methoxyestradiol intravenous injection, preparation Complicated process and other issues, to achieve good industrialization and commercialization prospects, simple preparation process, high drug loading effect

Inactive Publication Date: 2017-12-01
HENAN UNIV OF SCI & TECH
View PDF5 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] The Chinese invention patent 2-methoxyestradiol intravenous nanoemulsion whose publication number is CN 101249070A consists of 0.05% to 0.5% of 2-methoxyestradiol in weight to volume ratio, 5% to 50% of injection oil, emulsified 0.05% to 5% of the agent, 2% to 6% of the isotonic regulator, the pH regulator and the balance are made of water for injection, and the preparation process is complicated.
[0006] There is no relevant report on self-emulsifying 2-methoxyestradiol intravenous injection

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] The self-emulsifying 2-methoxyestradiol intravenous injection of the present invention is made of the following raw materials in percentage by weight: 10% of 2-methoxyestradiol, 10% of saturated caprylic triglyceride, 15% of soybean lecithin, ethanol 65%.

[0034] The preparation method of self-emulsifying 2-methoxyestradiol intravenous injection of the present invention comprises the following steps:

[0035] Mix the formula amount of saturated caprylic triglyceride, soybean lecithin, and ethanol evenly, dissolve, add the formula amount of 2-methoxyestradiol to dissolve, and then form a clear and transparent self-emulsifying 2-methoxyestradiol preparation. When in use, take 1 mL of the injection and add it to 5 mL of normal saline, and shake gently to form an emulsion. The particle size is 156 nm and the PDI is 0.152 as measured by dynamic light scattering.

Embodiment 2

[0037] The self-emulsifying 2-methoxyestradiol intravenous injection of the present invention is made of the following raw materials in percentage by weight: 5% of 2-methoxyestradiol, 10% of soybean oil, 50% of Tween80 and 35% of propylene glycol.

[0038] The preparation method of self-emulsifying 2-methoxyestradiol intravenous injection of the present invention comprises the following steps:

[0039] Mix the soybean oil, Tween80 and propylene glycol in the formulated amount evenly, dissolve them, add the 2-methoxyestradiol in the formulated amount to dissolve, and then form a clear and transparent 2-methoxyestradiol self-emulsifying preparation. When in use, take 1 mL of the injection and add it to 5 mL of 5% glucose, and shake gently to form an emulsion with light blue opalescence. The particle size is 56 nm and PDI 0.152 as measured by dynamic light scattering.

Embodiment 3

[0041] The self-emulsifying 2-methoxyestradiol intravenous injection of the present invention is made of the following raw materials in percentage by weight: 1% 2-methoxyestradiol, 5% soybean oil, 40% Pluronic F68, polyethylene glycol 400 54%.

[0042] The preparation method of self-emulsifying 2-methoxyestradiol intravenous injection of the present invention comprises the following steps:

[0043] Mix the soybean oil, Pluronic F68, and polyethylene glycol 400 in the formulated amount, dissolve them, add the 2-methoxyestradiol in the formulated amount, and dissolve to form a clear and transparent self-emulsifying 2-methoxyestradiol preparation.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Particle sizeaaaaaaaaaa
Particle sizeaaaaaaaaaa
Particle sizeaaaaaaaaaa
Login to View More

Abstract

The invention relates to a self-emulsified 2-methoxyestradiol intravenous injection and a preparation method thereof, and belongs to the field of medicinal preparation. The self-emulsified 2-methoxyestradiol intravenous injection comprises, by weight, 0.1-10% of 2-methoxyestradiol, 4.9-30% of oil for injection, 10-80% of emulsifier and 0-85% of co-emulsifier. The prepared self-emulsified 2-methoxyestradiol intravenous injection is high in drug-loading rate and good in stability and has a certain targeting ability, the efficacy is increased, the toxic and side effects are reduced, and safety is good; and the preparation technology is simple, the cost is low, and good industrialization and commercialization prospects are achieved.

Description

technical field [0001] The invention relates to a self-emulsifying 2-methoxyestradiol intravenous injection and a preparation method thereof, belonging to the field of pharmaceutical preparations. Background technique [0002] 2-Methoxyestradiol is a steroid hormone compound, an endogenous metabolite of estradiol, and belongs to a new type of hormone antitumor drug. Since the 1990s, a large number of studies have shown that 2-methoxyestradiol has the effects of inducing tumor cell apoptosis and differentiation, anti-tumor angiogenesis, and inhibiting tumor cell proliferation. , breast cancer, liver cancer, gastric cancer, etc., have anti-tumor activity. [0003] Clinical studies have shown that 2-methoxyestradiol is active orally, but, like other steroid hormones, 2-ME has poor solubility, the solubility in water is about 2μg / mL, and the bioavailability after oral administration is low, and After oral administration, its pharmacokinetics in vivo are irregular, and there is...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K9/107A61K47/14A61K47/24A61K47/10A61K47/44A61K47/26A61K47/12A61K47/22A61K47/28A61K31/565A61P35/00
CPCA61K9/0019A61K9/107A61K31/565A61K47/10A61K47/12A61K47/14A61K47/22A61K47/24A61K47/26A61K47/28A61K47/44
Inventor 和素娜李杰李瑞芳王建刚吴银萍王学廷
Owner HENAN UNIV OF SCI & TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products